Arthur R. Nemiroff is Director at Targeted Medical Pharma, Inc. (TRGM). They have made 1 open-market trade across 1 company since 2013, most recently 2013-11-19.
CIK 0001509592
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PrivateUnlisted | 29,000 | — |
| TRGM | 45,000 | — |
| Total | $0 |
Shares reported on the most recent Form 4, priced at the 2013-11-25 close. 2 holdings could not be priced and are excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TRGM | SELL | 2013-11-19 | 2013-11-25 | $0.91 | $8K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.